Consensus Confluent, Inc.

Equities

CFLT

US20717M1036

Market Closed - Nasdaq 04:00:03 2024-05-31 pm EDT 5-day change 1st Jan Change
25.95 USD -5.84% Intraday chart for Confluent, Inc. -16.29% +10.90%

Evolution of the average Target Price on Confluent, Inc.

Price target over the last 5 years

History of analyst recommendation changes

87fdf31fc0aefde29b32e59876.WWvrMN2Fq2Y4i-TL9CXJf6wPNQg8n7ACeq3wK4JiSaE.DTyRfZHi6AhIypWekxeHEPZpZX1Z04E7KcS4SMsBLeUKJ4ZokNPKFm_utQ~c0f849a6046ee22a29ac6cc24090562b
Confluent Insider Sold Shares Worth $1,944,436, According to a Recent SEC Filing MT
Baptista Research Starts Confluent With Hold Rating, $35.60 Price Target MT
Confluent Insider Sold Shares Worth $7,372,575, According to a Recent SEC Filing MT
Oppenheimer Initiates Coverage on Confluent With Outperform Rating, $37 Price Target MT
Confluent Insider Sold Shares Worth $1,975,599, According to a Recent SEC Filing MT
Confluent Insider Sold Shares Worth $2,231,961, According to a Recent SEC Filing MT
Goldman Sachs Raises Price Target on Confluent to $30 From $27, Maintains Neutral Rating MT
Wells Fargo Raises Price Target on Confluent to $38 From $36, Maintains Overweight Rating MT
Truist Adjusts Price Target on Confluent to $36 From $33, Maintains Buy Rating MT
Canaccord Genuity Upgrades Confluent to Buy From Hold With $35 Price Target MT
UBS Adjusts Price Target on Confluent to $30 From $28, Maintains Neutral Rating MT
Mizuho Securities Cuts Price Target on Confluent to $36 From $38, Maintains Buy Rating MT
Confluent Insider Sold Shares Worth $252,283, According to a Recent SEC Filing MT
Needham Raises Price Target on Confluent to $38 From $35, Maintains Buy Rating MT
Stifel Starts Confluent With Buy Rating, $40 Price Target MT
RBC Lifts PT on Confluent to $37 From $35, Notes Increased Confidence in 2024 Outlook, Multi-Year Opportunity; Outperform Kept MT
UBS Adjusts Confluent Price Target to $28 From $26, Maintains Neutral Rating MT
Canaccord Genuity Adjusts Price Target on Confluent to $28 From $26, Maintains Hold Rating MT
Capital One Adjusts Price Target on Confluent to $38 From $27, Maintains Overweight Rating MT
Piper Sandler Adjusts Price Target on Confluent to $37 From $30, Maintains Overweight Rating MT
Barclays Adjusts Price Target on Confluent to $33 From $26, Maintains Overweight Rating MT
JMP Securities Adjusts Price Target on Confluent to $38 From $25, Maintains Market Outperform Rating MT
FBN Securities Adjusts Price Target on Confluent to $35 From $25, Maintains Outperform Rating MT
DA Davidson Raises Price Target on Confluent to $37 From $24, Maintains Buy Rating MT
Loop Capital Raises Price Target on Confluent to $30 From $23, Maintains Hold Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
25.95 USD
Average target price
35.31 USD
Spread / Average Target
+36.05%
High Price Target
42 USD
Spread / Highest target
+61.85%
Low Price Target
28 USD
Spread / Lowest Target
+7.90%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Confluent, Inc.

Baptista Research
Oppenheimer
Goldman Sachs
Wells Fargo Securities
Truist Securities
Canaccord Genuity
UBS
Mizuho Securities
Needham & Co.
Stifel Nicolaus
RBC Capital Markets
DA Davidson
Capital One Securities
Piper Sandler
Barclays
JMP Securities
FBN Securities
Loop Capital
Bernstein
Morgan Stanley
JPMorgan Chase
Scotiabank
Deutsche Bank Securities
Guggenheim
Wolfe Research
BofA Securities
Citigroup
MoffettNathanson Research
TD Cowen
Cowen
Credit Suisse
William Blair & Co.
Arete
KeyBanc Capital Markets
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
  1. Stock Market
  2. Equities
  3. CFLT Stock
  4. Consensus Confluent, Inc.